1. Executive Summary
2. Global Medication Management Market
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. Research Methodology
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. Average Pricing Analysis
5. Macro-Economic Indicators
6. Market Dynamics
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7. Correlation & Regression Analysis
7.1. Correlation Matrix
7.2. Regression Matrix
8. Recent Development, Policies & Regulatory Landscape
9. Risk Analysis
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10. Global Hospital Beds Market Analysis
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11. Global Medication Management Market
11.1. Market Size & forecast, 2019A-2030F
11.1.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11.1.2. By Volume (Million Units) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12. Global Medication Management Market: Market Segmentation
12.1. By Regions
12.1.1. North America:(U.S. and Canada) By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.2. Europe: (Brazil, Mexico, Argentina, Rest of Latin America) By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.3. Asia-Pacific: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe) By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.4. LATAM: (Brazil, South Africa, Saudi Arabia, U.A.E. and Other Countries) By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.5. MEA: (Brazil, South Africa, Saudi Arabia, U.A.E. and Other Countries) By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2. By Software Type: Market Share (2020-2030F)
12.2.1. CPOE, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.2. CDSS, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.3. Medication Administration Software, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.4. Inventory Management, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.5. ADS, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.6. Others, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.3. By Service: Market Share (2020-2030F)
12.3.1. Medication Analytics Services, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.3.2. ADE Surveillance Services, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.3.3. Point-Of-Care Verification Services, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.4. By Mode of Delivery: Market Share (2020-2030F)
12.4.1. Web-Based, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.4.2. Cloud-Based, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.4.3. On-Premises, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.5. By End User: Market Share (2020-2030F)
12.5.1. Hospitals, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.5.2. Pharmacy, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.5.3. Others, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
14. A-S Medication Solutions.
14.1. Company Overview
14.2. Company Total Revenue (Financials)
14.3. Market Potential
14.4. Global Presence
14.5. Key Performance Indicators
14.6. SWOT Analysis
14.7. Product Launch
15. ARxIUM.
16. Becton, Dickinson and Company.
17. Cerner Corporation
18. GE Healthcare
19. McKesson Corporation.
20. Omnicell, Inc.
21. Talyst, LLC.
22. McKesson Corporation
23. Other Prominent Players
The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
Select License Type